DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Schering-Plough

News

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...

News

Merck to Pay $688 Million to Settle Enhance Lawsuits

15.02.2013 - Merck & Co has agreed to pay $688 million to settle two U.S. class-action lawsuits by shareholders who said they lost money because the company concealed the poor results of a...

News

Merck Loses Bid To Recoup $473 Million In U.S.

21.06.2011 - A federal appeals court rejected Merck & Co's bid for a new trial to obtain $472.9 million of federal income tax refunds that the drugmaker believes it deserves. The 3rd U.S...

News

Merck's Dutch R&D Unit To Keep Some Jobs, Change Focus

07.04.2011 - U.S. drugmaker Merck & Co., which last year said it would close three research sites in the Netherlands, on Thursday said it would keep about half of the research and development...

Plant Construction & Process Technology

Patent Cliff To Intensify in the U.S. in 2011

21.01.2011 - Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic...

News

White Knight Could Be Elusive For Genzyme

02.08.2010 - Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...

News

Merck & Co Closing Sites In Post-Merger Restructuring

09.07.2010 - Merck & Co announced plans to close eight research sites and eight manufacturing sites as it restructures in the wake of its merger with rival drugmaker Schering-Plough Corp. Merck...

News

Merck to Seek 5 New Drug Approvals This Year

12.05.2010 - Merck & Co plans to seek approval for five new medicines this year, including a closely watched hepatitis C treatment, but has halted development of an experimental anemia medicine...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.